what are the glp-1 agonists receptor increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Potential Use of GLP-1 and
Description
However, challenges include higher costs and limited long-term safety data, necessitating further studies to confirm its cardiovascular benefits in non-diabetic populations and cerebrovascular conditions, such as vascular dementia [15]
It plays a vital role in stimulating insulin secretion, slowing gastric emptying, and reducing appetite, thus helping maintain balanced blood sugar levels and supporting weight management
How is the Opportunistic Rise of the Middle East and Africa in the GLP-1 Market
2021;12:1321 10.3390/mi12111321
As promised, here are infographics of suggestions for management of GLP-1 and GIP side effects
